Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma-Reference-Cited by-同舟云学术

Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma

Published:2000-04 Issue:1 Volume:109 Page:138-147
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Lahuerta Juan José,Martinez-Lopez Joaquín,Grande Carlos,Bladé Joan,Serna Javier De La,Alegre Adrián,García-Laraña José,Caballero Dolores,Sureda Ana,Rubia Javier De La,Alvarez Ana M.,Marín Julian,Escudero Antonio,Conde Eulogio,Perez-Equiza Katy,García Ruiz Juan C.,Moraleda José M.,León Angel,Bargay Juan,Cabrera Rafael,Hernandez-García Miguel T.,Diaz-Mediavilla Joaquín,Miguel Jesús San

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2000.01979.x/fullpdf

Reference40 articles.

1. Phase I trial of dacarbacine with cyclophosphamide, etoposide, carmustine, and autologous bone marrow transplantation for advanced lymphoma and myeloma;Adkins;Proceedings of the Annual Meeting of the American Society of Clinical Oncology,1992

2. Busulphan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma;Alegre;British Journal of Haematology,1995

3. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry;Alegre;Bone Marrow Transplantation,1998

4. Early myeloablative therapy for multiple myeloma;Alexanian;Blood,1994

5. Intensive combined therapy for previously untreated aggressive myeloma;Attal;Blood,1992

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015);Annals of Hematology;2023-07-01

2. Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome;Leukemia & Lymphoma;2022-11-23

3. Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study;Blood;2022-05-05

4. Pretransplant Determinants of Outcome in Patients with Myeloma Undergoing Autologous Transplantation in Lower Resource Settings;European Medical Journal;2021-06-17

5. Exploratory analysis of intensified conditioning as first line treatment for patients with high risk multiple myeloma;Hematological Oncology;2020-07-29